Figure 2.
Plasminogen activator–induced dissolution of fibrin clots. (A) Fibrin clots containing plasminogen and varying amounts of myosin were prepared in microtiter plates and the activator-induced lysis was monitored as described in “Materials and methods.” The concentration of myosin in the clots was 0 (solid line), 0.2 μM (dotted line), or 2 μM (dashed and dotted line). The symbols indicate the mean of the t1/2 lysis time and its SE determined from 5 replicate measurements. The inset shows the lysis time in relative units (the t1/2 of fibrin without myosin is 1) determined under identical conditions for 0.3 μM tPA(•) and 0.15 μM urokinase (○) in quadruplicate samples. (B) Plasma clot formation and tPA-induced dissolution was monitored as described in “Materials and methods.” Representative curves are shown for plasma clots with no myosin (solid line), 0.5 μM myosin (dotted line), and 3 μM myosin (dashed and dotted line). • indicate the lysis time of the respective sample.

Plasminogen activator–induced dissolution of fibrin clots. (A) Fibrin clots containing plasminogen and varying amounts of myosin were prepared in microtiter plates and the activator-induced lysis was monitored as described in “Materials and methods.” The concentration of myosin in the clots was 0 (solid line), 0.2 μM (dotted line), or 2 μM (dashed and dotted line). The symbols indicate the mean of the t1/2 lysis time and its SE determined from 5 replicate measurements. The inset shows the lysis time in relative units (the t1/2 of fibrin without myosin is 1) determined under identical conditions for 0.3 μM tPA(•) and 0.15 μM urokinase (○) in quadruplicate samples. (B) Plasma clot formation and tPA-induced dissolution was monitored as described in “Materials and methods.” Representative curves are shown for plasma clots with no myosin (solid line), 0.5 μM myosin (dotted line), and 3 μM myosin (dashed and dotted line). • indicate the lysis time of the respective sample.

Close Modal

or Create an Account

Close Modal
Close Modal